A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex (R) in patients with anaemia of chronic renal failure

A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-alpha) vs. Eprex (R) in patients with anaemia of chronic renal failure

Background: Erythropoietin stimulating agent (ESA) has been standard of care in treating renal anaemia for the past 20 years. Many patients have limited access to ESA in view of long-term costs leading to suboptimal ESA dosage. Biosimilar epoetin is a potential cost-effective alternative to originat...

Full description

Saved in:
Bibliographic Details
Main Authors: Lim, Soo Kun, Goh, Bak Leong, Visvanathan, Ravindran, Kim, Su Hyun, Jeon, Jin Seok, Kim, Sung Gyun, Chang, Jae Hyun, Lim, Chun Soo, Morad, Zaki
Format: Article
Published: BioMed Central 2021
Subjects:
R Medicine (General)
Online Access:http://eprints.um.edu.my/34215/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya

Internet

http://eprints.um.edu.my/34215/

Similar Items